Set per infusione & Terapia 
Dispositivi per infusione neria™
I set per infusione neria™ sono indicati per la somministrazione di farmaci per infusione continua sottocutanea.
I prodotti neria™ sono stati testati (in vitro) per l'infusione continua sottocutanea di:
- Apomorfina per il morbo di Parkinson1 :
- deferoxamina (neria™) per Talassemia2
- Immunoglobuline (IgG) per Immunodeficienza Primitiva3
- Idromorfone, morfina solfato e cloridrato per la Terapia del Dolore4,5
- Stability test and function test of Comfort and Contact Detach by means of the medicament APO-go. Analysis report no. 294690. January 14-April 1, 2009. Data on file. Unomedical.
- Drug Device Stability Test Thalaset – Study Desferal (deferoxamine mesilate). July 1, 2005. Data on file. Unomedical.
- Compatibility and stability testing of the catheter device Unomedical comfort™ with the immunoglobulin Subcuvia. IKFE 09016. April 16, 2009. Data on file. Unomedical.
- Drug Compatibility Study of Three Infusion Devices with Morphine Sulfate, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.
- Drug Compatibility Study of Three Infusion Devices with Hydromorphone Hydrochloride, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.